DermAb.io

Miriam Oron Ph.D. will be presenting DermAb.io  alongside esteemed speakers Hadas Ziso Daniella Gilboa and Avital Adler, PhD at the upcoming New England - Israel Business Council webinar ! Meital Portugal, PhD Maura Rosenfeld MindUP - The Digital Health Incubator Viki Gronau, MBA

💡 𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐰𝐨𝐦𝐞𝐧'𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐜𝐮𝐭𝐭𝐢𝐧𝐠-𝐞𝐝𝐠𝐞 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧? 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐚𝐧 𝐞𝐯𝐞𝐧𝐭 𝐲𝐨𝐮 𝐝𝐨𝐧’𝐭 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐦𝐢𝐬𝐬! Join our CEO Miriam Oron Ph.D. on Thursday, October 17 for a virtual event hosted by Women of Wearables. Miriam will share DermAb.io’s pioneering approach to personalized biologic therapies that address the unique needs of women with autoimmune diseases. With a focus on reducing the trial-and-error process of treatments, our technology is bringing better healthcare outcomes to women everywhere. 📅 Date: Thursday, October 17 🕕 Time: 6 - 8pm IDT 📍 Location: Online 🔗 𝐒𝐚𝐯𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲 𝐚𝐧𝐝 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐰𝐨𝐦𝐞𝐧’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 >> https://lnkd.in/dYaCDJCQ #WomensHealth #Biotech #Innovation #AutoimmuneTherapies Meital Portugal, PhD, Maura Rosenfeld, Sivan Sadan, Ludmila LE GOHEBEL, Ann Deren-Lewis, MindUP - The Digital Health Incubator, FEMMUNE

Register today for the upcoming FEMMUNE webinar! https://lnkd.in/dC9U9SzP Viki Gronau, MBA #womenhealth #autoimmune #Femtech

Many intrinsic processes and pathologies are reflected in the skin, either clinically by cutaneous symptoms or sub-clinically by alterations in skin biomarkers. DermAb.io’s skin biomarker platform leverages information from human skin to predict response to biological drugs used to treat autoimmune and chronic diseases.  Our mission is to allow providers to prescribe the right drug for their patients the first time, bringing significant savings to payers and relief to patients.   Thank you NoCamels - Israeli Tech & Innovation News for providing this stage to DermAb.io https://lnkd.in/dMZa5yzu   Miriam Oron Ph.D. Meital Portugal, PhD Maura Rosenfeld Ann Deren-Lewis MindUP - The Digital Health Incubator Sivan Sadan Kathrin Schoenborn Ludmila L. FEMMUNE Viki Gronau, MBA   #autoimmune #autoimmunediseases #womenshealth

The month of August is Psoriasis Awareness Month, a chance to raise awareness about a condition that affects more than 8 million Americans. Psoriasis speeds up skin cell growth, leading to itchy, scaly patches that can show up just about anywhere. It’s more than skin-deep, though—it can also bring joint pain and other health issues along for the ride. There are five types of psoriasis, with plaque psoriasis being the most common. It often starts between ages 15 and 25 but can happen at any age. While the exact cause is still a mystery, the immune system and genetics definitely play key roles. DermAb.io is stepping up with a clinical decision support tool that helps doctors prescribe the right biologic therapy for chronic and autoimmune diseases like psoriasis. Our non-invasive tech painlessly retrieves biomarkers from the skin’s surface, providing valuable insights that help doctors pick the most effective treatment from the get-go. This means less trial and error, saving time, costs, and a lot of discomfort. https://lnkd.in/dkDGhmWv #PsoriasisAwarenessMonth #Psoriasis #AutoimmuneDisease #HealthcareInnovation Meital Portugal, PhD Miriam Oron Ph.D. MindUP - The Digital Health Incubator Maura Rosenfeld Ann Deren-Lewis Ludmila L.

DermAb.io had the honor of hosting the AbbVie Israel team yesterday at MindUP - The Digital Health Incubator. Dan Shwarzman shared insights on entrepreneurship and the start up eco-system, and Zvika Shinar explained how to assess new technologies and the challenge of being innovative while meeting market needs and potential business cases. This was followed by a meeting with some of the portfolio companies, as well as DermAb.io’s technology and its grassroots FEMMUNE initiative. We were all very inspired by their curiosity, inspiring questions, and observations. It was a pleasure to host you, Moran Barak, Dr. Inbal Piller Maor, and the entire AbbVie Israel team. We look forward to more meetings and future collaborations.    Miriam Oron Ph.D. Meital Portugal, PhD Kathrin Schoenborn Maura Rosenfeld Sivan Sadan  Dr Ronell Klingman (Bernstein) MD Viki Gronau, MBA   #autoimmune #autoimmunediseases #biomarkers #womenshealth

Hello from the showcase and finale of the MassChallenge Israel! We're here at our booth, showcasing how DermAb.io is unlocking the potential of skin biomarkers. Come learn about our latest advancements! Big thanks to the MassChallenge Israel team for this incredible opportunity! Miriam Oron Ph.D. Meital Portugal, PhD Maura Rosenfeld MindUP - The Digital Health Incubator Sivan Sadan Ludmila L. Zvika Shinar Viki Gronau, MBA Kathrin Schoenborn #Innovation #SkinBiomarkers #HealthcareTech  

Skin biomarkers are important indicators in the sub-clinical level Many systemic diseases and disorders are accompanied by changes in skin biomarkers profiles . This is why skin biomarkers have a huge potential to serve as a tool for predicting, monitoring, and managing autoimmune and chronic diseases. Here are some compelling examples of diseases that have been shown to be reflected in skin biomarker profile: ✔ Neurodegenerative diseases such as Parkinson’s and Alzheimer’s ✔Chronic kidney diseases ✔Diabetes type II ✔Covid-19 Meital Portugal, PhD Miriam Oron Ph.D. Maura Rosenfeld MindUP - The Digital Health Incubator Sivan Sadan #autoimmune #autoimmunediseases #biomarkers

Skin biomarkers are important indicators in the sub-clinical level Many systemic diseases and disorders are accompanied by changes in skin biomarkers profiles . This is why skin biomarkers have a huge potential to serve as a tool for predicting, monitoring, and managing autoimmune and chronic diseases. Here are some compelling examples of diseases that have been shown to be reflected in skin biomarker profile: ✔ Neurodegenerative diseases such as Parkinson’s and Alzheimer’s ✔Chronic kidney diseases ✔Diabetes type II ✔Covid-19 Meital Portugal, PhD Miriam Oron Ph.D. Maura Rosenfeld MindUP - The Digital Health Incubator Sivan Sadan #autoimmune #autoimmunediseases #biomarkers

Today is the International #DayofActionforWomensHealth, a day that serves as a global call to action to prioritize and advocate for women's health rights and gender equality. While the spotlight often focuses on reproductive health and maternal care, it's essential to recognize and address the pervasive disparities that extend beyond these realms. One such area of concern is the disproportionate burden of autoimmune diseases faced by women. Autoimmune diseases, a diverse group of conditions characterized by the immune system mistakenly attacking the body's own tissues, affect millions worldwide, with over 80 recognized autoimmune disorders. There is a striking predominance of autoimmune diseases in women, with estimates suggesting that up to 80% of those afflicted are female. The consequences of this gender gap in autoimmune diseases are far-reaching, extending beyond mere statistics to encompass profound implications for diagnosis, treatment, and quality of life. Women often experience delays in diagnosis, as symptoms may be dismissed or attributed to other causes, leading to underrecognition and undertreatment of these conditions. Furthermore, women with autoimmune diseases face unique challenges, including reproductive health concerns, pregnancy-related complications, and the impact of hormonal fluctuations on disease severity. That’s why it is imperative to focus on the gender disparities in autoimmune disease. This entails not only raising awareness but also advocating for comprehensive research initiatives, improved diagnostic criteria, and gender-sensitive healthcare policies. Empowering women with autoimmune diseases to voice their experiences, access timely and equitable care, and participate in decision-making processes is essential to achieving meaningful progress. #autoimmune #autoimmunediseases #womenshealth